The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Chemotherapy and Dietary Phytochemical Agents
Open accessAbstract
Chemotherapy has been used for cancer treatment already for almost 70 years by targeting the proliferation potential and metastasising ability of tumour cells. Despite the progress made in the development of potent chemotherapy drugs, their toxicity to normal tissues and adverse side effects in multiple organ systems as well as drug resistance have remained the major obstacles for the successful clinical use. Cytotoxic agents decrease considerably the quality of life of cancer patients manifesting as acute complaints and impacting the life of survivors also for years after the treatment. Toxicity often limits the usefulness of anticancer agents being also the reason why many patients discontinue the treatment. The nutritional approach may be the means of helping to raise cancer therapy to a new level of success as supplementing or supporting the body with natural phytochemicals cannot only reduce adverse side effects but improve also the effectiveness of chemotherapeutics. Various plant-derived compounds improve the efficiency of cytotoxic agents, decrease their resistance, lower and alleviate toxic side effects, reduce the risk of tumour lysis syndrome, and detoxify the body of chemotherapeutics. The personalised approach using various phytochemicals provides thus a new dimension to the standard cancer therapy for improving its outcome in a complex and complementary way.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Cold Spring Harbor Symposia on Quantitative Biology.
Berg, H. (1989) · Journal of Electroanalytical Chemistry and Interfacial Electrochemistry · doi:10.1016/0022-0728(89)87283-3 · Cited by 1,144
Candidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
Montazeri, A. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-32 · Cited by 770
Repopulation of cancer cells during therapy: an important cause of treatment failure
Kim, J. J., & Tannock, I. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1650 · Cited by 686
Is folic acid good for everyone?
Smith, A. D., Kim, Y.-I., & Refsum, H. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.517 · Cited by 612
Metabolism and cancer: the circadian clock connection
Sahar, S., & Sassone-Corsi, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2747 · Cited by 551
Dietrich, J., Han, R., Yang, Y., Mayer-Pröschel, M., & Noble, M. (2006) · Journal of Biology · doi:10.1186/jbiol50 · Cited by 500
Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
Lawenda, B. D., Kelly, K. M., Ladas, E. J., Sagar, S. M., Vickers, A., & Blumberg, J. B. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn148 · Cited by 472
Antioxidants and cancer, part 3: quercetin.
Lamson, D. W., & Brignall, M. S. (2000) · PubMed · Cited by 414
Salganik, R. I. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719185 · Cited by 402
Cairns, R., Papandreou, I., & Denko, N. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0002 · Cited by 370
Metastasis: a therapeutic target for cancer
Steeg, P. S., & Theodorescu, D. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1066 · Cited by 332
Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M. (2008) · Journal of Biology · doi:10.1186/jbiol69 · Cited by 316
Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs
Constantinou, C., Papas, A., & Constantinou, A. I. (2008) · International Journal of Cancer · doi:10.1002/ijc.23689 · Cited by 281
Antioxidants in cancer therapy; their actions and interactions with oncologic therapies.
Lamson, D. W., & Brignall, M. S. (1999) · PubMed · Cited by 279
Scambia, G., Ranelletti, F. O., Panici, P. B., De Vincenzo, R., Bonanno, G., Ferrandina, G., Piantelli, M., Bussa, S., Rumi, C., Cianfriglia, M., et al. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685655 · Cited by 271
Gorbacheva, V. Y., Kondratov, R. V., Zhang, R., Cherukuri, S., Gudkov, A. V., Takahashi, J. S., & Antoch, M. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409897102 · Cited by 270
Cancer and ageing: a nexus at several levels
Balducci, L., & Ershler, W. B. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1675 · Cited by 250
Sagar, S. M., Yance, D., & Wong, R. K. (2006) · Current Oncology · doi:10.3747/co.v13i1.77 · Cited by 243
Csoka, A. B., & Szyf, M. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.10.039 · Cited by 241
Wätjen, W., Michels, G., Steffan, B., Niering, P., Chovolou, Y., Kampkötter, A., Tran-Thi, Q.-H., Proksch, P., & Kahl, R. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.3.525 · Cited by 240
Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Bansal, T., Jaggi, M., Khar, R., & Talegaonkar, S. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3rc77 · Cited by 238
The detoxification enzyme systems.
Liska, D. J. (1998) · PubMed · Cited by 237
Ju, Y. H., Doerge, D. R., Allred, K. F., Allred, C. D., & Helferich, W. G. (2002) · PubMed · Cited by 235
The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
Wu, C.-P., Hsieh, C.-H., & Wu, Y.-S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200261n · Cited by 234
Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review
Liu, F.-S. (2009) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60296-5 · Cited by 220
Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided
D'Andrea, G. M. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.5.319 · Cited by 217
The anticancer effects of vitamin K.
Lamson, D. W., & Plaza, S. M. (2003) · PubMed · Cited by 213
α-Tocopheryl Succinate, the Most Effective Form of Vitamin E for Adjuvant Cancer Treatment: A Review
Prasad, K. N., Kumar, B., Yan, X.-D., Hanson, A. J., & Cole, W. C. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719283 · Cited by 208
Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy
J.E. Trosko, B. S. P., & R.J. Ruch, B. S. P. (2002) · Current Drug Targets · doi:10.2174/1389450023347371 · Cited by 196
Melatonin in Cancer Management: Progress and Promise
Jung, B., & Ahmad, N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1776 · Cited by 196
Ghosh, K., Thodeti, C. K., Dudley, A. C., Mammoto, A., Klagsbrun, M., & Ingber, D. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800835105 · Cited by 188
Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats
SHIN, S., CHOI, J., & LI, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.028 · Cited by 176
Adenosine Receptors and Cancer
Fishman, P., Bar‐Yehuda, S., Synowitz, M., Powell, J. D., Klotz, K., Gessi, S., & Borea, P. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_14 · Cited by 170
Reactive Oxygen Species, Cancer and Anti-Cancer Therapies
Nechifor, M. T., Neagu, T.-M., & Manda, G. (2009) · Current Chemical Biology · doi:10.2174/2212796810903010022 · Cited by 161
Role of stem cells in cancer therapy and cancer stem cells: a review
Sagar, J., Chaib, B., Sales, K. M., Winslet, M. C., & Seifalian, A. M. (2007) · Cancer Cell International · doi:10.1186/1475-2867-7-9 · Cited by 152
Possible acceleration of aging by adjuvant chemotherapy: A cause of early onset frailty?
MacCormick, R. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.045 · Cited by 150
Ginseng leaf-stem: bioactive constituents and pharmacological functions
Wang, H., Peng, D., & Xie, J. (2009) · Chinese Medicine · doi:10.1186/1749-8546-4-20 · Cited by 148
LaPensee, E. W., Tuttle, T. R., Fox, S. R., & Ben‐Jonathan, N. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11788 · Cited by 145
Antioxidants and Cancer III: Quercetin
Lamson, D. W., & Brignall, M. S. (2001) · Cited by 140
Neužil, J., Tomasetti, M., Zhao, Y., Dong, L., Birringer, M., Wang, X., Low, P., Wu, K., Salvatore, B. A., & Ralph, S. J. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.030122 · Cited by 139
Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells
Kitagawa, S., Nabekura, T., & Kamiyama, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044003 · Cited by 126
Potential Role of Ginseng in the Treatment of Colorectal Cancer
Wang, C., & Yuan, C. (2008) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x08006545 · Cited by 114
Lévi, F., Filipski, E., Iurisci, I., Li, X. M., & Innominato, P. F. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.030 · Cited by 102
P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs
Eichhorn, T., & Efferth, T. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.08.053 · Cited by 101
Recurrence cancer stem cells – Made by cell fusion?
Dittmar, T., Nagler, C., Schwitalla, S., Reith, G., Niggemann, B., & Zänker, K. S. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.05.044 · Cited by 100
Sliutz, G., Karlseder, J., Tempfer, C. M., Orel, L., Holzer, G., & Simon, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.334 · Cited by 98
Zhang, Q. H., Wu, C. F., Duan, L., & Yang, J. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.08.025 · Cited by 95
Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells
Wang, C., Luo, X., Zhang, B., Song, W.-X., Ni, M., Mehendale, S. R., Xie, J.-T., Aung, H. H., He, T., & Yuan, C.-S. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0350-2 · Cited by 93
Influence of Tangeretin on Tamoxifen's Therapeutic Benefit in Mammary Cancer
Bracke, M. E., Depypere, H. T., Boterberg, T., Marck, V., Vennekens, K., Vanluchene, E., Nuytinck, M., Serreyn, R. F., & Mareel, M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.354 · Cited by 90
Antioxidants in Cancer Therapy
Prasad, K. N., & Cole, W. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1327 · Cited by 89
Aging and Inflammation: Etiological Culprits of Cancer
Ahmad, A., Banerjee, S., Wang, Z. P., Kong, D., Majumdar, A. P. N., & Sarkar, F. H. (2009) · Current Aging Science · doi:10.2174/1874609810902030174 · Cited by 87
Li, X., & Choi, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.002 · Cited by 85
Sagar, S. M., Yance, D. R., & Wong, R. K. (2006) · Current Oncology · doi:10.3747/co.v13i3.88 · Cited by 82
Modulation of cancer chemotherapy by green tea.
Sadzuka, Y., Sugiyama, T., & Hirota, S. (1998) · PubMed · Cited by 80
The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours
Constantinou, A. I., White, B. E. P., Tonetti, D. A., Yang, Y., Liang, W., Li, W., & van Breemen, R. B. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.005 · Cited by 78
Prasad, K. N., Cole, W. C., Kumar, B., & Prasad, K. C. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719184 · Cited by 76
Circadian Clock Genes as Modulators of Sensitivity to Genotoxic Stress
Antoch, M. P., Kondratov, R. V., & Takahashi, J. S. (2005) · Cell Cycle · doi:10.4161/cc.4.7.1792 · Cited by 75
Jia, W. W.-G., Bu, X., Philips, D., Yan, H., Liu, G., Chen, X., Bush, J., & Li, G. (2004) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-049 · Cited by 74
Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells
Ding, W., Liu, B., Vaught, J. L., Palmiter, R. D., & Lind, S. E. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0067 · Cited by 65
Sugiyama, T., & Sadzuka, Y. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00185-2 · Cited by 63
Al-Tonbary, Y. A., Al-Haggar, M. S., El-Ashry, R. A., El-Dakroory, S., Azzam, H., & Fouda, A. E. (2009) · Advances in Hematology · doi:10.1155/2009/689639 · Cited by 62
American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats
Mehendale, S. R., Aung, H. H., Wang, A., Yin, J., Wang, C., Xie, J., & Yuan, C. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0956-1 · Cited by 61
Shen, F., Xue, X., & Weber, G. (1999) · PubMed · Cited by 53
Lu, D.-Y., Chen, X. L., & Ding, J. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.07.023 · Cited by 52
Lin, L.-C., Wang, M.-N., & Tsai, T. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.05.033 · Cited by 48
Antioxidants and cancer therapy II: quick reference guide.
Lamson, D. W., & Brignall, M. S. (2000) · PubMed · Cited by 39
Nicolson, G. L. (2005) · Pathology & Oncology Research · doi:10.1007/bf02893390 · Cited by 35
Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562
Hoffman, R. M., Graham, L., & Newlands, E. S. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.68 · Cited by 33
Presurgical Systemic Treatment of Nonmetastatic Breast Cancer: Facts and Open Questions
Berruti, A., Brizzi, M. P., Generali, D., Ardine, M., Dogliotti, L., Bruzzi, P., & Bottini, A. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0162 · Cited by 32
An Attempt to Evaluate the Effect of Vitamin K3 Using as an Enhancer of Anticancer Agents
Matzno, S., Yamaguchi, Y., Akiyoshi, T., Nakabayashi, T., & Matsuyama, K. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1270 · Cited by 30
Harless, W. W., & Qiu, Y. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.032 · Cited by 30
Parris, G. E. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.05.036 · Cited by 28
Clock genes in health and diseases
Mongrain, V., & Cermakian, N. (2009) · Journal of Applied Biomedicine · doi:10.32725/jab.2009.002 · Cited by 23
Cianfriglia, M., Mancuso, S., Scambia, G., et al. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050173 · Cited by 23
Haus, E. L. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.08.045 · Cited by 16
Chemo brain – A psychotropic drug phenomenon?
Jackson, G. E. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.06.019 · Cited by 15
A novel vicious cycle cascade in tumor chemotherapy
Zhou, H., Zou, P., Chen, Z., & You, Y. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.03.038 · Cited by 13
Symptom control trials: a 20-year experience.
Loprinzi, C. L., Barton, D. L., Jatoi, A., Sloan, J. A., MARTENSON, J., Steensma, D. P., Rao, R. D., Novotny, P. J., Sood, A., Grothey, A. F., et al. (2007) · PubMed · Cited by 12
Could visible light contribute to the development of leukaemia and other cancers in children?
Erren, T. C. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.09.021 · Cited by 12
A built-in co-carcinogenic effect due to viruses involved in latent or persistent infections
Hersoug, L., & Arnau, J. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.009 · Cited by 2
Cited by
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Teleanu, R. I., Chircov, C., Grumezescu, A. M., & Teleanu, D. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010084 · Cited by 503
Liu, Y.-Q., Wang, X.-L., He, D.-H., & Cheng, Y.-X. (2021) · Phytomedicine · doi:10.1016/j.phymed.2020.153402 · Cited by 259
Metadata
- Authors
- Sak, K.
- Venue
- Chemotherapy Research and Practice
- Publisher
- Hindawi Limited
- Published
- 2012-12-20
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 2090-2107 (ISSN-L)
- 2090-2115
- OpenAlex
- W2121318534
- Cited by
- 310
- References
- 85
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.